You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 19, 2025

Drug Price Trends for GNP MUCUS RELIEF DM MAX LIQUID


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for GNP MUCUS RELIEF DM MAX LIQUID

Average Pharmacy Cost for GNP MUCUS RELIEF DM MAX LIQUID

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
GNP MUCUS RELIEF DM MAX LIQUID 46122-0371-30 0.01970 ML 2024-06-19
GNP MUCUS RELIEF DM MAX LIQUID 46122-0371-30 0.01970 ML 2024-05-22
GNP MUCUS RELIEF DM MAX LIQUID 46122-0371-30 0.01871 ML 2024-04-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for GNP MUCUS RELIEF DM MAX LIQUID

Introduction to GNP MUCUS RELIEF DM MAX LIQUID

GNP MUCUS RELIEF DM MAX LIQUID is an over-the-counter (OTC) medication designed to provide relief from cough and chest congestion. It contains the active ingredients dextromethorphan HBr, a cough suppressant, and guaifenesin, an expectorant that helps thin and loosen mucus, making coughs more productive[1].

Market Size and Growth

The market for expectorant and cough suppressant drugs, which includes products like GNP MUCUS RELIEF DM MAX LIQUID, is expected to experience significant growth. The expectorant drugs market is projected to reach USD 120 million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 4.5% from 2024 to 2029[3].

Global Demand and Regional Insights

The demand for expectorant and cough suppressant drugs has been driven by the rise in respiratory illnesses, including those associated with COVID-19. The Asia Pacific region is expected to be the fastest-growing market for these medications, while North America holds the largest market share[3].

Product Specifics and Benefits

GNP MUCUS RELIEF DM MAX LIQUID is formulated to provide fast and effective relief from cough and chest congestion. Here are some key benefits:

  • Cough Suppression: Dextromethorphan HBr helps to temporarily relieve cough due to minor throat and bronchial irritation[1].
  • Expectorant Properties: Guaifenesin helps loosen phlegm (mucus) and thin bronchial secretions, making coughs more productive[1].
  • Convenience: Available in a liquid form, making it easier to administer, especially for those who have difficulty swallowing tablets.

Price Trends

The prices for GNP MUCUS RELIEF DM MAX LIQUID can vary depending on the retailer and location. Here are some general price ranges:

  • GNP MUCUS RELIEF DM MAX 6OZ: Typically priced around $10.29[4].
  • Leader Maximum Strength Mucus Relief DM Liquid: Priced at approximately $4.99 for a 1-liter bottle, which translates to about $0.50 per 100ml[5].

Market Drivers

Several factors are driving the growth of the expectorant and cough suppressant drugs market:

  • Increased Respiratory Illnesses: The rise in respiratory illnesses, including those associated with COVID-19, has increased the demand for these medications[3].
  • Consumer Preferences: Consumers are looking for reliable, affordable, and effective options for managing respiratory symptoms. Products like GNP MUCUS RELIEF DM MAX LIQUID, which offer quick and long-lasting relief, are well-received by consumers[3].

Challenges and Opportunities

  • Supply Chain Strains: The increased demand can strain supply chains, leading to potential shortages. However, this also presents an opportunity for manufacturers to scale up production and meet the growing demand[3].
  • Regulatory Compliance: Ensuring compliance with evolving regulatory requirements is crucial for maintaining market presence. For example, regulations related to the use of certain ingredients in children must be adhered to[3].

Consumer Preferences and Satisfaction

Consumers are increasingly seeking products that are reliable, affordable, and provide long-lasting relief. GNP MUCUS RELIEF DM MAX LIQUID, with its fast-acting and extended relief properties, aligns well with these consumer preferences. The satisfaction guarantee and quality assurance from brands further enhance consumer trust[3].

Future Outlook

Given the projected growth of the expectorant and cough suppressant drugs market, GNP MUCUS RELIEF DM MAX LIQUID is likely to see continued demand. The product's formulation and comparison to well-known brands like Mucinex position it well in the market.

Key Statistics

  • Market Size: Expected to reach USD 120 million by 2029[3].
  • CAGR: 4.5% from 2024 to 2029[3].
  • Fastest Growing Region: Asia Pacific[3].
  • Largest Market: North America[3].

Key Takeaways

  • The expectorant and cough suppressant drugs market is expected to grow significantly due to increased respiratory illnesses.
  • GNP MUCUS RELIEF DM MAX LIQUID offers fast and effective relief from cough and chest congestion.
  • The product is well-positioned in the market with its liquid formulation and comparison to well-known brands.
  • Regulatory compliance and supply chain management are crucial for market success.

FAQs

Q: What are the active ingredients in GNP MUCUS RELIEF DM MAX LIQUID? A: The active ingredients are dextromethorphan HBr (20 mg) and guaifenesin (400 mg) per 20 mL[1].

Q: What is the expected market size of the expectorant drugs market by 2029? A: The expectorant drugs market is expected to reach USD 120 million by 2029[3].

Q: Which region is the fastest-growing market for expectorants? A: The Asia Pacific region is the fastest-growing market for expectorants[3].

Q: How does GNP MUCUS RELIEF DM MAX LIQUID compare to other products in the market? A: It is comparable to Mucinex in terms of its active ingredients and benefits, providing fast and effective relief from cough and chest congestion[1][4].

Q: What are the key benefits of using GNP MUCUS RELIEF DM MAX LIQUID? A: It helps loosen phlegm, thin bronchial secretions, and temporarily relieves cough due to minor throat and bronchial irritation[1].

Sources

  1. DailyMed: MUCUS RELIEF DM MAXIMUM STRENGTH - dextromethorphan hbr, guaifenesin liquid.
  2. Drugs.com: Mucus Relief DM Prices, Coupons, Copay Cards & Patient Assistance.
  3. DrugPatentWatch: QC MUCUS RLF MAX Market Analysis and Financial Projection.
  4. Galloway Sands Pharmacy: GNP MUCUS RELIEF DM MAX 6OZ.
  5. Food Lion: Leader Maximum Strength Mucus Relief DM Liquid.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.